Aileron Therapeutics' Series E - II Round

Aileron Therapeutics raised a round of funding on October 29, 2014.

Aileron Therapeutics (NASDAQ: ALRN) is a biopharmaceutical company developing and advancing a class of drugs called Stapled Peptides. The company's Stapled Peptides platform is a breakthrough approach…

Articles about Aileron Therapeutics' Series E - II Round: